Special Feature

User Panel

My Panel

My Panel

Bookmark Science Articles

Recent News
Bookmark / Share This Science Site

Nitric oxide attenuates epithelial-mesenchymal transition in alveolar epithelial cells.

Nitric oxide attenuates epithelial-mesenchymal transition in alveolar epithelial cells. Research Abstract Details 

Research Abstract Table of Contents

Jump to the:

  • Abstract Text of This Paper
  • Journal Published
  • MeSH Keywords of This Abstract
  • Chemicals and Substances Used in this Paper
  • Grants and Granting Agency of this Research
  • Database Accession Numbers Used in this Paper
  • Related Papers
  • Related Research Tags
  • Rate this Research Paper
  • Nitric oxide attenuates epithelial-mesenchymal transition in alveolar epithelial cells. Abstract Text:

    shilpa vyas-readShilpa Vyas-Read,philip w shaulPhilip W Shaul,ivan s yuhannaIvan S Yuhanna,brigham c willisBrigham C Willis,

    Patients with interstitial lung diseases, such as idiopathic pulmonary fibrosis (IPF) and bronchopulmonary dysplasia (BPD), suffer from lung fibrosis secondary to myofibroblast-mediated excessive ECM deposition and destruction of lung architecture. Transforming growth factor (TGF)-beta1 induces epithelial-mesenchymal transition (EMT) of alveolar epithelial cells (AEC) to myofibroblasts both in vitro and in vivo. Inhaled nitric oxide (NO) attenuates ECM accumulation, enhances lung growth, and decreases alveolar myofibroblast number in experimental models. We therefore hypothesized that NO attenuates TGF-beta1-induced EMT in cultured AEC. Studies of the capacity for endogenous NO production in AEC revealed that endothelial nitric oxide synthase (eNOS) and inducible nitric oxide synthase (iNOS) are expressed and active in AEC. Total NOS activity was 1.3 pmol x mg protein(-1) x min(-1) with 67% derived from eNOS. TGF-beta1 (50 pM) suppressed eNOS expression by more than 60% and activity by 83% but did not affect iNOS expression or activity. Inhibition of endogenous NOS with l-NAME led to spontaneous EMT, manifested by increased alpha-smooth muscle actin (alpha-SMA) expression and a fibroblast-like morphology. Provision of exogenous NO to TGF-beta1-treated AEC decreased stress fiber-associated alpha-SMA expression and decreased collagen I expression by 80%. NO-treated AEC also retained an epithelial morphology and expressed increased lamellar protein, E-cadherin, and pro-surfactant protein B compared with those treated with TGF-beta alone. These findings indicate that NO serves a critical role in preserving an epithelial phenotype and in attenuating EMT in AEC. NO-mediated regulation of AEC fate may have important implications in the pathophysiology and treatment of diseases such as IPF and BPD.

    Nitric oxide attenuates epithelial-mesenchymal transition in alveolar epithelial cells. Publishing Authors By Initials

    s vyas-readS Vyas-Read,pw shaulPW Shaul,is yuhannaIS Yuhanna,bc willisBC Willis,

    For similar peptides: intercellular signaling peptides and proteins: cytokines: transforming growth factor beta: transforming growth factor beta1 research abstracts see: peptides: intercellular signaling peptides and proteins: cytokines: transforming growth factor beta: transforming growth factor beta1 research

    PUBMED ID PMID:

    MEDLINE DATE:

    Nitric oxide attenuates epithelial-mesenchymal transition in alveolar epithelial cells. Journal Published:

    PUBLICATION TYPE: Research Support, Non-U.S. Gov

    Journal: American journal of physiology. Lung cellular and

    VOLUME: 293

    Page Numbers: L212-21

    Journal Abbreviation: Am. J. Physiol. Lung Cell Mol.

    ISSN: 1040-0605

    DAY: 11

    MONTH: 05

    YEAR: 2007

    Nitric oxide attenuates epithelial-mesenchymal transition in alveolar epithelial cells. Information

    Number of References:

    LANGUAGE: eng

    NlmUniqueID: 100901229

    Nitric oxide attenuates epithelial-mesenchymal transition in alveolar epithelial cells. Keywords Mesh Terms:

    KEYWORDS: Transforming Growth Factor beta1

    MESH TERMS: pharmacology

    Chemical & Substance for Abstract: Nitric oxide attenuates epithelial-mesenchymal transition in alveolar epithelial cells. Information

    Substance Name: Nitric Oxide Synthase

    Registry Number: EC 1.14.13.39

    Grant and Affiliation Information for Nitric oxide attenuates epithelial-mesenchymal transition in alveolar epithelial cells.

    AFFILIATION: Division of Neonatal-Perinatal Medicine, Department of Pediatrics, University of Texas Southwestern Medical Center, Dallas, Texas 75390-9063, USA.

    Country: United States

    United States Research PublicationUnited States Research Publication

    AGENCY: United States NHLBI

    GRANT: U01-HL-63399

    ACRONYM: HL

    MEDLINETA: Am J Physiol Lung Cell Mol Phy

    REFSOURCE:

    DATABASENAME:

    ACCESSION NUMBER:

    Number Hits: 0

    Nitric oxide attenuates epithelial-mesenchymal transition in alveolar epithelial cells Related Publications

     

    Molecular Station USER Menu

    Welcome to Molecular Station!

    You have to register before you can post on our forums or use our advanced features. Register Now! Its Free and Fast!

    Already registered? Login now below.

    User Name:

    Password:

    Already registered and Forgot your password? Click below to recover it.

    Recover Lost Password

    Join now - it's fast and free!

    Molecular Station is THE largest network of researchers, scientists and science lovers anywhere!

    Research Terms of Usage and Disclaimer
    Home
    Features

    Protocols

    DNA Forum

    Science Forum

    DNA Forum
    Biology Forum

    Science News


    [CaRP] XML error: Invalid document end at line 2

    For more click here:Science News